Pharmanutra Pharmanutra_pr Stock: price and insider trades · Italy
Pharmanutra Pharmanutra_pr: what insiders have been doing
Pharmanutra Pharmanutra_pr has a thin disclosure history in our data (latest filing: 16 April 2024). New filings will appear here as soon as they are published. Source: insider filings from Consob. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 8,116 of 26,911 companies
61.5
score / 100
Value38
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€83.00
Analyst consensus
3 analysts1.00/5
€76.00Target €81.33(-2%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.7x
PER (forward)27.1x
P/Book10.7x
Beta0.17
Balance sheet & cash
Market cap€794.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions17.2%
Last declaration on 16 April 2024
Declarations1 total
- ●Executives0Consob
1 of 1 declaration
About Pharmanutra Pharmanutra_pr
Pharmanutra is a company specialized in the health and pharmaceutical sector, providing innovative products for well-being. It is listed on the XMIL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
